SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-09-20

AUTHORS

Axel S. Merseburger, Andrea B. Apolo, Simon Chowdhury, Noah M. Hahn, Matthew D. Galsky, Matthew I. Milowsky, Daniel Petrylak, Tom Powles, David I. Quinn, Jonathan E. Rosenberg, Arlene Siefker-Radtke, Guru Sonpavde, Cora N. Sternberg

ABSTRACT

The SIU (Société Internationale d’Urologie)–ICUD (International Consultation on Urologic Diseases) working group on systemic therapy for metastatic bladder cancer has summarized the most recent findings on the aforementioned topic and came to conclusions and recommendations according to the evidence published. In Europe and the United States, treatment for metastatic UC has changed a great deal recently, mainly involving a move from chemotherapy to immune checkpoint blockers. This is particularly true in platinum-refractory disease, where supportive randomized data exist. Five checkpoint blockers have been approved in this setting by the FDA: avelumab, atezolizumab, durvalumab, nivolumab, and pembrolizumab. Nivolumab, pembrolizumab, and atezolizumab have been approved in Europe. More... »

PAGES

95-105

Journal

TITLE

World Journal of Urology

ISSUE

1

VOLUME

37

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00345-018-2486-1

DOI

http://dx.doi.org/10.1007/s00345-018-2486-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107121688

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30238401


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal, Humanized", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Immunological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carboplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Transitional Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cisplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Deoxycytidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methotrexate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nivolumab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Paclitaxel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urinary Bladder Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vinblastine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Urology, Campus L\u00fcbeck, University Hospital Schleswig-Holstein, L\u00fcbeck, Germany", 
          "id": "http://www.grid.ac/institutes/grid.412468.d", 
          "name": [
            "Department of Urology, Campus L\u00fcbeck, University Hospital Schleswig-Holstein, L\u00fcbeck, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Merseburger", 
        "givenName": "Axel S.", 
        "id": "sg:person.0754343671.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754343671.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Cancer Research, National Cancer Institute, NIH Maryland, Bethesda, USA", 
          "id": "http://www.grid.ac/institutes/grid.417768.b", 
          "name": [
            "Center for Cancer Research, National Cancer Institute, NIH Maryland, Bethesda, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Apolo", 
        "givenName": "Andrea B.", 
        "id": "sg:person.01004324342.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004324342.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Guy\u2019s and St, Thomas\u2019 Hospital, Great Maze Pond, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.425213.3", 
          "name": [
            "Guy\u2019s and St, Thomas\u2019 Hospital, Great Maze Pond, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chowdhury", 
        "givenName": "Simon", 
        "id": "sg:person.01127443652.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127443652.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA", 
          "id": "http://www.grid.ac/institutes/grid.21107.35", 
          "name": [
            "Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hahn", 
        "givenName": "Noah M.", 
        "id": "sg:person.0616302533.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616302533.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA", 
          "id": "http://www.grid.ac/institutes/grid.59734.3c", 
          "name": [
            "Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Galsky", 
        "givenName": "Matthew D.", 
        "id": "sg:person.0674341075.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674341075.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.10698.36", 
          "name": [
            "Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Milowsky", 
        "givenName": "Matthew I.", 
        "id": "sg:person.014641236037.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014641236037.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yale Cancer Center, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.433818.5", 
          "name": [
            "Yale Cancer Center, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Petrylak", 
        "givenName": "Daniel", 
        "id": "sg:person.01241754603.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241754603.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Barts Cancer Institute, London, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Barts Cancer Institute, London, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Powles", 
        "givenName": "Tom", 
        "id": "sg:person.016205207357.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016205207357.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Quinn", 
        "givenName": "David I.", 
        "id": "sg:person.01013134010.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013134010.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Memorial Sloan Kettering Cancer Center, New York, USA", 
          "id": "http://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Memorial Sloan Kettering Cancer Center, New York, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rosenberg", 
        "givenName": "Jonathan E.", 
        "id": "sg:person.01042672613.79", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042672613.79"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Siefker-Radtke", 
        "givenName": "Arlene", 
        "id": "sg:person.0617467327.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617467327.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Bladder Cancer Center, Dana Farber Cancer Institute, Boston, MA, USA", 
          "id": "http://www.grid.ac/institutes/grid.65499.37", 
          "name": [
            "Department of Medical Oncology, Bladder Cancer Center, Dana Farber Cancer Institute, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sonpavde", 
        "givenName": "Guru", 
        "id": "sg:person.016233207575.67", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016233207575.67"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy", 
          "id": "http://www.grid.ac/institutes/grid.416308.8", 
          "name": [
            "Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sternberg", 
        "givenName": "Cora N.", 
        "id": "sg:person.01354346024.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354346024.40"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bjc.6603118", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042033781", 
          "https://doi.org/10.1038/sj.bjc.6603118"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10637-006-9020-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026239180", 
          "https://doi.org/10.1007/s10637-006-9020-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1006159525793", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040943607", 
          "https://doi.org/10.1023/a:1006159525793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10147-011-0188-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043301285", 
          "https://doi.org/10.1007/s10147-011-0188-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-09-20", 
    "datePublishedReg": "2018-09-20", 
    "description": "The SIU (Soci\u00e9t\u00e9 Internationale d\u2019Urologie)\u2013ICUD (International Consultation on Urologic Diseases) working group on systemic therapy for metastatic bladder cancer has summarized the most recent findings on the\u00a0aforementioned topic and came to conclusions and recommendations according to the evidence published. In Europe and the United States, treatment for metastatic UC has changed a great deal recently, mainly involving a move from chemotherapy to immune checkpoint blockers. This is particularly true in platinum-refractory disease, where supportive randomized data exist. Five checkpoint blockers have been approved in this setting by the FDA: avelumab, atezolizumab, durvalumab, nivolumab, and pembrolizumab. Nivolumab, pembrolizumab, and atezolizumab have been approved in Europe.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00345-018-2486-1", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438793", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2438805", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2724233", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1094127", 
        "issn": [
          "0724-4983", 
          "1433-8726"
        ], 
        "name": "World Journal of Urology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "keywords": [
      "metastatic bladder cancer", 
      "bladder cancer", 
      "systemic therapy", 
      "checkpoint blockers", 
      "platinum-refractory disease", 
      "immune checkpoint blockers", 
      "metastatic UC", 
      "cancer", 
      "atezolizumab", 
      "nivolumab", 
      "blockers", 
      "therapy", 
      "recent findings", 
      "Working Group", 
      "durvalumab", 
      "data exists", 
      "avelumab", 
      "chemotherapy", 
      "disease", 
      "FDA", 
      "United States", 
      "treatment", 
      "recommendations", 
      "conclusion", 
      "UC", 
      "group", 
      "findings", 
      "setting", 
      "evidence", 
      "Soci\u00e9t\u00e9 Internationale", 
      "great deal", 
      "exists", 
      "Europe", 
      "Internationale", 
      "topic", 
      "state", 
      "deal", 
      "Siu", 
      "moves"
    ], 
    "name": "SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer", 
    "pagination": "95-105", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107121688"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00345-018-2486-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30238401"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00345-018-2486-1", 
      "https://app.dimensions.ai/details/publication/pub.1107121688"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_761.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00345-018-2486-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00345-018-2486-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00345-018-2486-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00345-018-2486-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00345-018-2486-1'


 

This table displays all metadata directly associated to this object as RDF triples.

306 TRIPLES      21 PREDICATES      84 URIs      72 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00345-018-2486-1 schema:about N0203187eb1ec4ade9cd53781e513b9b0
2 N36c6a375df6447d6bda9582142424b22
3 N5686ee1047bd4baa8190ef2779774fb2
4 N5b27524360814f33bed2648ee6ff2026
5 N5cee8364b85241218addfafc1449ebeb
6 N6039c41758b2401eac4c0062d13c4393
7 N62e4896a861845d0b13fcc596b567ef0
8 N6a4efe568f49431cb9b7f12adf879bf5
9 N7457cc282738488d8e291c9fa86d39b1
10 N7623067bb2584bf09a513fa68a3bb1e3
11 N7761d41069404c48829973233325c700
12 N9f2accc21b6447c8b81ee610c17c0677
13 Na30ee62df38141bcb8852ec76cbb52db
14 Na8a2b653c3f54e3e9e56559ee7815168
15 Nb2718592bb37476baf365ba4121defd1
16 Nba8f1fd8736d43c392f52aaec32699a8
17 anzsrc-for:11
18 anzsrc-for:1112
19 schema:author N2562b0d369814798b5ac6670eae44969
20 schema:citation sg:pub.10.1007/s10147-011-0188-4
21 sg:pub.10.1007/s10637-006-9020-9
22 sg:pub.10.1023/a:1006159525793
23 sg:pub.10.1038/sj.bjc.6603118
24 schema:datePublished 2018-09-20
25 schema:datePublishedReg 2018-09-20
26 schema:description The SIU (Société Internationale d’Urologie)–ICUD (International Consultation on Urologic Diseases) working group on systemic therapy for metastatic bladder cancer has summarized the most recent findings on the aforementioned topic and came to conclusions and recommendations according to the evidence published. In Europe and the United States, treatment for metastatic UC has changed a great deal recently, mainly involving a move from chemotherapy to immune checkpoint blockers. This is particularly true in platinum-refractory disease, where supportive randomized data exist. Five checkpoint blockers have been approved in this setting by the FDA: avelumab, atezolizumab, durvalumab, nivolumab, and pembrolizumab. Nivolumab, pembrolizumab, and atezolizumab have been approved in Europe.
27 schema:genre article
28 schema:isAccessibleForFree true
29 schema:isPartOf N6ae8908397834d8d88ebbb4899a85e55
30 Nb45520b76d80409e9c311e8d5bcd2b1f
31 sg:journal.1094127
32 schema:keywords Europe
33 FDA
34 Internationale
35 Siu
36 Société Internationale
37 UC
38 United States
39 Working Group
40 atezolizumab
41 avelumab
42 bladder cancer
43 blockers
44 cancer
45 checkpoint blockers
46 chemotherapy
47 conclusion
48 data exists
49 deal
50 disease
51 durvalumab
52 evidence
53 exists
54 findings
55 great deal
56 group
57 immune checkpoint blockers
58 metastatic UC
59 metastatic bladder cancer
60 moves
61 nivolumab
62 platinum-refractory disease
63 recent findings
64 recommendations
65 setting
66 state
67 systemic therapy
68 therapy
69 topic
70 treatment
71 schema:name SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer
72 schema:pagination 95-105
73 schema:productId N63cf05c17f9e4f6eae3c8a64abbacb36
74 N676e78710e894de5afed4d17359349d1
75 Ne4686615f8b9449b942a915f01def165
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107121688
77 https://doi.org/10.1007/s00345-018-2486-1
78 schema:sdDatePublished 2022-09-02T16:01
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher N350c9b8cb1854c4b97a1a2f78df00c04
81 schema:url https://doi.org/10.1007/s00345-018-2486-1
82 sgo:license sg:explorer/license/
83 sgo:sdDataset articles
84 rdf:type schema:ScholarlyArticle
85 N0203187eb1ec4ade9cd53781e513b9b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Nivolumab
87 rdf:type schema:DefinedTerm
88 N2562b0d369814798b5ac6670eae44969 rdf:first sg:person.0754343671.23
89 rdf:rest N47f182869c054442a20dc7c8530dfd94
90 N29c4a2bd827547cfb18276468dff03c0 rdf:first sg:person.014641236037.41
91 rdf:rest Ncf5a7552289344348df764ba2bcb8eff
92 N2cec82da7a0c44e8abceafbc866c3782 rdf:first sg:person.0616302533.19
93 rdf:rest N5d1e8722452a401b80eafbf9162a53cb
94 N350c9b8cb1854c4b97a1a2f78df00c04 schema:name Springer Nature - SN SciGraph project
95 rdf:type schema:Organization
96 N36c6a375df6447d6bda9582142424b22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Carcinoma, Transitional Cell
98 rdf:type schema:DefinedTerm
99 N3ae0a79add5643048d1f0eb0ce710522 rdf:first sg:person.016233207575.67
100 rdf:rest N883e51915f8f447ba6022aa682fbb37b
101 N3cd3b189f7574b678186ee589bf4bf38 rdf:first sg:person.01013134010.15
102 rdf:rest N8bc4709c3516449ca1e345abfa137e50
103 N3f3389f3eb23498b8b8e09c353453316 rdf:first sg:person.016205207357.68
104 rdf:rest N3cd3b189f7574b678186ee589bf4bf38
105 N47d93c00f3f94965874bc52f3b89e970 rdf:first sg:person.0617467327.15
106 rdf:rest N3ae0a79add5643048d1f0eb0ce710522
107 N47f182869c054442a20dc7c8530dfd94 rdf:first sg:person.01004324342.95
108 rdf:rest Na72bf309866f490aa44caa280386a96b
109 N5686ee1047bd4baa8190ef2779774fb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Liver Neoplasms
111 rdf:type schema:DefinedTerm
112 N5b27524360814f33bed2648ee6ff2026 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Antibodies, Monoclonal, Humanized
114 rdf:type schema:DefinedTerm
115 N5cee8364b85241218addfafc1449ebeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Doxorubicin
117 rdf:type schema:DefinedTerm
118 N5d1e8722452a401b80eafbf9162a53cb rdf:first sg:person.0674341075.72
119 rdf:rest N29c4a2bd827547cfb18276468dff03c0
120 N6039c41758b2401eac4c0062d13c4393 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Methotrexate
122 rdf:type schema:DefinedTerm
123 N62e4896a861845d0b13fcc596b567ef0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Paclitaxel
125 rdf:type schema:DefinedTerm
126 N63cf05c17f9e4f6eae3c8a64abbacb36 schema:name doi
127 schema:value 10.1007/s00345-018-2486-1
128 rdf:type schema:PropertyValue
129 N676e78710e894de5afed4d17359349d1 schema:name dimensions_id
130 schema:value pub.1107121688
131 rdf:type schema:PropertyValue
132 N6a4efe568f49431cb9b7f12adf879bf5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Antineoplastic Combined Chemotherapy Protocols
134 rdf:type schema:DefinedTerm
135 N6ae8908397834d8d88ebbb4899a85e55 schema:issueNumber 1
136 rdf:type schema:PublicationIssue
137 N7457cc282738488d8e291c9fa86d39b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Vinblastine
139 rdf:type schema:DefinedTerm
140 N7623067bb2584bf09a513fa68a3bb1e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Antineoplastic Agents, Immunological
142 rdf:type schema:DefinedTerm
143 N7761d41069404c48829973233325c700 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Antibodies, Monoclonal
145 rdf:type schema:DefinedTerm
146 N883e51915f8f447ba6022aa682fbb37b rdf:first sg:person.01354346024.40
147 rdf:rest rdf:nil
148 N8bc4709c3516449ca1e345abfa137e50 rdf:first sg:person.01042672613.79
149 rdf:rest N47d93c00f3f94965874bc52f3b89e970
150 N9f2accc21b6447c8b81ee610c17c0677 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Cisplatin
152 rdf:type schema:DefinedTerm
153 Na30ee62df38141bcb8852ec76cbb52db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Deoxycytidine
155 rdf:type schema:DefinedTerm
156 Na72bf309866f490aa44caa280386a96b rdf:first sg:person.01127443652.34
157 rdf:rest N2cec82da7a0c44e8abceafbc866c3782
158 Na8a2b653c3f54e3e9e56559ee7815168 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Carboplatin
160 rdf:type schema:DefinedTerm
161 Nb2718592bb37476baf365ba4121defd1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Urinary Bladder Neoplasms
163 rdf:type schema:DefinedTerm
164 Nb45520b76d80409e9c311e8d5bcd2b1f schema:volumeNumber 37
165 rdf:type schema:PublicationVolume
166 Nba8f1fd8736d43c392f52aaec32699a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Humans
168 rdf:type schema:DefinedTerm
169 Ncf5a7552289344348df764ba2bcb8eff rdf:first sg:person.01241754603.97
170 rdf:rest N3f3389f3eb23498b8b8e09c353453316
171 Ne4686615f8b9449b942a915f01def165 schema:name pubmed_id
172 schema:value 30238401
173 rdf:type schema:PropertyValue
174 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
175 schema:name Medical and Health Sciences
176 rdf:type schema:DefinedTerm
177 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
178 schema:name Oncology and Carcinogenesis
179 rdf:type schema:DefinedTerm
180 sg:grant.2438793 http://pending.schema.org/fundedItem sg:pub.10.1007/s00345-018-2486-1
181 rdf:type schema:MonetaryGrant
182 sg:grant.2438805 http://pending.schema.org/fundedItem sg:pub.10.1007/s00345-018-2486-1
183 rdf:type schema:MonetaryGrant
184 sg:grant.2724233 http://pending.schema.org/fundedItem sg:pub.10.1007/s00345-018-2486-1
185 rdf:type schema:MonetaryGrant
186 sg:journal.1094127 schema:issn 0724-4983
187 1433-8726
188 schema:name World Journal of Urology
189 schema:publisher Springer Nature
190 rdf:type schema:Periodical
191 sg:person.01004324342.95 schema:affiliation grid-institutes:grid.417768.b
192 schema:familyName Apolo
193 schema:givenName Andrea B.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004324342.95
195 rdf:type schema:Person
196 sg:person.01013134010.15 schema:affiliation grid-institutes:grid.42505.36
197 schema:familyName Quinn
198 schema:givenName David I.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013134010.15
200 rdf:type schema:Person
201 sg:person.01042672613.79 schema:affiliation grid-institutes:grid.51462.34
202 schema:familyName Rosenberg
203 schema:givenName Jonathan E.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01042672613.79
205 rdf:type schema:Person
206 sg:person.01127443652.34 schema:affiliation grid-institutes:grid.425213.3
207 schema:familyName Chowdhury
208 schema:givenName Simon
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01127443652.34
210 rdf:type schema:Person
211 sg:person.01241754603.97 schema:affiliation grid-institutes:grid.433818.5
212 schema:familyName Petrylak
213 schema:givenName Daniel
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241754603.97
215 rdf:type schema:Person
216 sg:person.01354346024.40 schema:affiliation grid-institutes:grid.416308.8
217 schema:familyName Sternberg
218 schema:givenName Cora N.
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354346024.40
220 rdf:type schema:Person
221 sg:person.014641236037.41 schema:affiliation grid-institutes:grid.10698.36
222 schema:familyName Milowsky
223 schema:givenName Matthew I.
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014641236037.41
225 rdf:type schema:Person
226 sg:person.016205207357.68 schema:affiliation grid-institutes:None
227 schema:familyName Powles
228 schema:givenName Tom
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016205207357.68
230 rdf:type schema:Person
231 sg:person.016233207575.67 schema:affiliation grid-institutes:grid.65499.37
232 schema:familyName Sonpavde
233 schema:givenName Guru
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016233207575.67
235 rdf:type schema:Person
236 sg:person.0616302533.19 schema:affiliation grid-institutes:grid.21107.35
237 schema:familyName Hahn
238 schema:givenName Noah M.
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616302533.19
240 rdf:type schema:Person
241 sg:person.0617467327.15 schema:affiliation grid-institutes:grid.240145.6
242 schema:familyName Siefker-Radtke
243 schema:givenName Arlene
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617467327.15
245 rdf:type schema:Person
246 sg:person.0674341075.72 schema:affiliation grid-institutes:grid.59734.3c
247 schema:familyName Galsky
248 schema:givenName Matthew D.
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0674341075.72
250 rdf:type schema:Person
251 sg:person.0754343671.23 schema:affiliation grid-institutes:grid.412468.d
252 schema:familyName Merseburger
253 schema:givenName Axel S.
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754343671.23
255 rdf:type schema:Person
256 sg:pub.10.1007/s10147-011-0188-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043301285
257 https://doi.org/10.1007/s10147-011-0188-4
258 rdf:type schema:CreativeWork
259 sg:pub.10.1007/s10637-006-9020-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026239180
260 https://doi.org/10.1007/s10637-006-9020-9
261 rdf:type schema:CreativeWork
262 sg:pub.10.1023/a:1006159525793 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040943607
263 https://doi.org/10.1023/a:1006159525793
264 rdf:type schema:CreativeWork
265 sg:pub.10.1038/sj.bjc.6603118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042033781
266 https://doi.org/10.1038/sj.bjc.6603118
267 rdf:type schema:CreativeWork
268 grid-institutes:None schema:alternateName Barts Cancer Institute, London, USA
269 schema:name Barts Cancer Institute, London, USA
270 rdf:type schema:Organization
271 grid-institutes:grid.10698.36 schema:alternateName Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA
272 schema:name Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA
273 rdf:type schema:Organization
274 grid-institutes:grid.21107.35 schema:alternateName Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA
275 schema:name Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA
276 rdf:type schema:Organization
277 grid-institutes:grid.240145.6 schema:alternateName Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
278 schema:name Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
279 rdf:type schema:Organization
280 grid-institutes:grid.412468.d schema:alternateName Department of Urology, Campus Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany
281 schema:name Department of Urology, Campus Lübeck, University Hospital Schleswig-Holstein, Lübeck, Germany
282 rdf:type schema:Organization
283 grid-institutes:grid.416308.8 schema:alternateName Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy
284 schema:name Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy
285 rdf:type schema:Organization
286 grid-institutes:grid.417768.b schema:alternateName Center for Cancer Research, National Cancer Institute, NIH Maryland, Bethesda, USA
287 schema:name Center for Cancer Research, National Cancer Institute, NIH Maryland, Bethesda, USA
288 rdf:type schema:Organization
289 grid-institutes:grid.42505.36 schema:alternateName Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA
290 schema:name Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA
291 rdf:type schema:Organization
292 grid-institutes:grid.425213.3 schema:alternateName Guy’s and St, Thomas’ Hospital, Great Maze Pond, London, UK
293 schema:name Guy’s and St, Thomas’ Hospital, Great Maze Pond, London, UK
294 rdf:type schema:Organization
295 grid-institutes:grid.433818.5 schema:alternateName Yale Cancer Center, New Haven, CT, USA
296 schema:name Yale Cancer Center, New Haven, CT, USA
297 rdf:type schema:Organization
298 grid-institutes:grid.51462.34 schema:alternateName Memorial Sloan Kettering Cancer Center, New York, USA
299 schema:name Memorial Sloan Kettering Cancer Center, New York, USA
300 rdf:type schema:Organization
301 grid-institutes:grid.59734.3c schema:alternateName Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA
302 schema:name Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA
303 rdf:type schema:Organization
304 grid-institutes:grid.65499.37 schema:alternateName Department of Medical Oncology, Bladder Cancer Center, Dana Farber Cancer Institute, Boston, MA, USA
305 schema:name Department of Medical Oncology, Bladder Cancer Center, Dana Farber Cancer Institute, Boston, MA, USA
306 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...